StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

Zivo Bioscience's gross margin for the twelve months ending Sep 30, 2025 was 31.7%. For fiscal 2024 it was 31.1%, against 42.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202431.1%−10.9
FY2023Dec 31, 202342.0%+75.1
FY2011Dec 31, 2011-33.1%−70.4
FY2010Dec 31, 201037.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 202532.4%−2.6
Q2 FY2025Jun 30, 202533.6%−1.4
Q4 FY2024Dec 31, 202430.0%−5.0
Q3 FY2024Sep 30, 202430.0%−52.7
Q1 FY2024Mar 31, 202435.0%–
Q4 FY2023Dec 31, 202335.0%–
Q3 FY2023Sep 30, 202335.0%–
Q2 FY2023Jun 30, 202382.7%–

More Zivo Bioscience figures

See a number that looks wrong?